RENEWING HEALTH - RegioNs of Europe WorkINg Together for HEALTH
- Conditions
- Coronary Artery DiseaseHeart FailureAtrial FibrillationOther ArrhythmiasType 2 Diabetes
- Interventions
- Behavioral: Health coaching
- Registration Number
- NCT01310491
- Lead Sponsor
- South Karelia, Social and Health Care District
- Brief Summary
The purpose of this trial is to determine if by structured telephone based health coaching programme supported by remote monitoring system among type 2 diabetes, coronary artery disease and heart failure patients the investigators are able to improve their quality of life as measured by the SF-36 questionnaire and reduce a value of HbA1c under 6,5 % among those type 2 diabetes patients who had elevated value of HbA1c when recruited.
- Detailed Description
RENEWING HEALTH is a project covering 9 different European States. It aims at evaluation of innovative telemedicine services using a patient-centred approach and a common rigorous assessment methodology. In 9 European regions in the implementation of health-related information and communication technologies service solutions are already operational at local level for the remote monitoring and the treatment of chronic patients suffering from diabetes,chronic obstructive pulmonary disease or cardiovascular diseases. The services are designed to give patients a central role in the management of their own diseases, fine-tuning the choice and dosage of medications, promoting compliance to treatment, and helping health care professionals to detect early signs of worsening in the monitored pathologies. Every area will designed its own real-life trial with certain common elements.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 595
-
Age > 18 years
-
Capability of filling in questionnaires in Finnish language.
-
Be able to use Remote Patient Monitoring System
-
Be able to use the devices provided
-
Has adequate cognitive capacities to participate
-
In their medical records, one or both of the following diagnoses:
a) Type 2 Diabetes, for enrolment
-
diagnosed over 3 months prior to the enrolment and
-
HbA1c > 6,5 % b) Heart Disease, for enrolment
-
Ischemic heart disease or
-
Heart Failure or
-
Atrial fibrillation or
-
Other arrhythmia
-
Be able to walk
- Not willing to participate (e.g., not willing to sign the consent)
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Usual Care Health coaching -
- Primary Outcome Measures
Name Time Method Health related quality of life 12 months Health related quality of life is assessed by the SF-36 questionnaire.
HbA1c change over time (participants with T2DM only) 12 months
- Secondary Outcome Measures
Name Time Method Weight reduction 12 months Activity increase 12 months Alcohol use reduction 12 months Medication compliance 12 months Blood pressure reduction 12 months Smoke cessation 12 months Cost for the organization 12 months Satisfaction and usability of the technology and equipments. 12 months
Trial Locations
- Locations (1)
Etelä-Karjalan sosiaali- ja terveydenhuollon kuntayhtymä
🇫🇮Lappeenranta, Finland